Skip to content

Clinical Study on the Treatment of Lumbar Intervertebral Disc Herniation with Weizhong Point Triple Puncture

Clinical Study on the Treatment of Lumbar Intervertebral Disc Herniation with Weizhong Point Triple Puncture

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300075092
Enrollment
Unknown
Registered
2023-08-24
Start date
2023-08-21
Completion date
Unknown
Last updated
2023-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lumbar disc herniation

Interventions

Treatment group:On the basis of the control group, cooperate with the Weizhong acupoint puncture method, that is, directly puncture the acupoint at the center by 1 inch. After obtaining qi through the
Control Group:The patient is lying flat on the treatment bed in a prone position, and after routine disinfection with 75% alcohol cotton balls, 0.30 mm is used × A 40-75mm millineedle is inserted usin
When needling the Shenshu acupoint, the sensation of the needle should be based on soreness in the waist and the patient s conscious comfort. During this time, twisting and thrusting are frequently pe

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Meets the diagnostic criteria of traditional Chinese and Western medicine, and the TCM syndrome types are blood stasis syndrome and cold dampness syndrome. (2) Age range from 30 to 65 years old (3) Voluntarily included in this clinical study and signed an informed consent form

Exclusion criteria

Exclusion criteria: (1) Low back pain caused by lumbar compression fractures, spinal stenosis, lumbar tuberculosis, tumors, etc (2) Low back pain caused by other internal medicine diseases (3) Patients with concomitant heart, liver, and kidney damage or severe consumptive diseases, abnormal coagulation function, and pregnant or lactating patients (4) Participants in other clinical trials (5) Unsigned informed consent

Design outcomes

Primary

MeasureTime frame
Efficacy and efficiency;

Secondary

MeasureTime frame
Visual Analogue Scale ;Japanese Orthopaedic Association Scores;Infrared thermal image value of lower back;Multifidus thickness;

Countries

China

Contacts

Public ContactXu Jingjing

Shanghai Sixth People's Hospital

826088211@qq.com+86 188 6567 2659

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026